Predicting the Risk of Pelvic Node Involvement Among Men With Prostate Cancer in the Contemporary Era: Change you can Believe in, or Back to the Future? (In Regard to Nguyen PL, et al. (Int J Radiat Oncol Biol Phys 2009)

International Journal of Radiation Oncology Biology Physics

Volumn 75, Issue 1, 2009, Pages 316-

  Roach III, Mack ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; RNA;

CANCER RADIOTHERAPY; CANCER RISK; DIAGNOSTIC ACCURACY; HUMAN; LETTER; LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

HUMANS; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MULTIVARIATE ANALYSIS; PELVIS; PROSTATIC NEOPLASMS; SEER PROGRAM;

EID: 68649103244     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.05.010     Document Type: Letter

References (9)

1. Roach III M. Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 1923-1924
2. Nguyen P.L., Chen M.H., Hoffman K.E., et al. Predicting the risk of pelvic node involvement among men with prostate cancer in the contemporary era. Int J Radiat Oncol Biol Phys 74 (2009) 104-109
3. Heidenreich A., Varga Z., and Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: High incidence of lymph node metastasis. J Urol 167 (2002) 1681-1686
4. Golimbu M., Morales P., Al-Askari S., et al. Extended pelvic lymphadenectomy for prostate cancer. J Urol 121 (1979) 617-620
5. Murray S.K., Breau R.H., Guha A.K., et al. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol 28 (2004) 1154-1162
6. Briganti A., Chun F.K., Salonia A., et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 69 (2007) 147-151
7. Pagliarulo V., Hawes D., Brands F.H., et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 24 (2006) 2735-2742
8. Shariat S.F., Kattan M.W., Erdamar S., et al. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splice variant-specific RT-PCR assay for human glandular kallikrein. J Clin Oncol 21 (2003) 1223-1231
9. Ferrari A.C., Stone N.N., Kurek R., et al. Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment. J Clin Oncol 24 (2006) 3081-3088